Navigation Links
Medicare HIT Incentive Update for the Oncology Practice - Free Educational Webinar
Date:7/18/2011

Federal Government Relations, McKesson Specialty Care Solutions | US Oncology

The presenters will draw from their experience with iKnowMed, an oncology-specific EHR that has achieved Complete Certification for Meaningful Use, and they will discuss what impact the Meaningful Use standards could have on community-based oncology practices. Other topics of discussion include an overview of Meaningful Use and recent proposed changes as well as important things for oncologists to consider before getting started on achieving Meaningful Use requirements. After the presentation, the speakers will hold an open discussion to address questions.

McKesson Specialty Care Solutions | US Oncology continues to invest in key areas including technology and quality programs to ensure that community-based oncologists and healthcare professionals are educated about pertinent topics. This event is being offered as a complimentary service and was designed to benefit physicians, practice administrators, and clinical staff.

About McKesson Specialty Care Solutions | US Oncology

McKesson Specialty Care Solutions | US Oncology, a division of McKesson Corporation, empowers the community patient care delivery system to advance the science, technology and quality of care. Through innovative clinical, research, business and operational solutions, facilitated by integrated technology systems, we improve the financial health of our customers and help them provide quality care for patients. For more information, visit www.mckesson.com/specialty and www.usoncology.com.

About McKesson

McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physici
'/>"/>

SOURCE US Oncology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
2. Study: Medicare Covers Only Half the Cost of Administering Chemotherapy to Seniors with Cancer
3. Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint(R)
4. Recently Approved Onglyza Is Covered by 44 Percent of Commercial Health Plans But Less Than One Percent of Medicare Plans for The Treatment of Type 2 Diabetes
5. Finance Committee Begins Markup - Lab Fee Converted to Medicare Cut
6. Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women
7. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
8. The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use
9. On-Line Medicare Advisor Saves Seniors Time, Hassle and Money
10. BioNeutral Group to Receive Economic Development Incentives
11. China Cord Blood Corporation Announces Cancellation of Nine Million Management Incentive Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... to their offering. This report ... of sequencing technologies, and their applications. Current large ... companies developing them. Various applications of sequencing are ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... , September 2, 2015 ... the winners of the 2015 BeHEARD science challenge, a ... offers rare disease researchers, access to the latest life ... its drug repositioning and pathway analytics capability to support ... Nation Foundation in the study of Niemann-Pick Disease Type ...
(Date:9/2/2015)... 2015 Australian prostate cancer technology company Minomic ... prize recognising ,outstanding, science that uses its patented antibody. ... a novel prostate cancer diagnostic test known as MiCheck® ... taking out the peer-reviewed Australian Museum Eureka Science Prize ... This prize is awarded for ground breaking research ...
Breaking Biology Technology:Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3
... Clinical and Commercial Adoption of the ... Axxent(R) Electronic Brachytherapy System, FREMONT, Calif., ... Brachytherapy System, a proprietary cancer treatment,platform that utilizes X-rays ... today announced that it will,present at the 26th Annual ...
... BioMarin will Continue to Manufacture; Genzyme will Continue to Market ... ... NOVATO, Calif. and CAMBRIDGE, Mass., Jan. 3 ,BioMarin Pharmaceutical ... ) announced today a restructuring of their joint venture,regarding Aldurazyme(R) ...
... Calif., Jan. 3 Thoratec,Corporation (Nasdaq: THOR ... disease, said today that it will be participating ... 9., Gary Burbach, president and chief executive ... at 8:30 a.m., Pacific Standard Time (11:30,a.m., Eastern ...
Cached Biology Technology:Xoft to Present at the 26th Annual JPMorgan Healthcare Conference 2BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 2BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 3BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 4BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 5
(Date:8/6/2015)... , Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon ... data. Crossmatch is a world leader in multi-factor ... expertise are helping federal agencies and commercial organizations ...   "The vast majority of network ...
(Date:8/5/2015)... CHICAGO , August 5, 2015 ... Identity & Access Management Market by Software, Services, Vertical (BFSI, ... Chemical/Pharma), & Geography - Global Forecast to 2020", published ... Access Management Market globally into various segments. The global ... in 2014 to $546.2 Million by 2019, at a ...
(Date:8/4/2015)... Research and ... addition of the "Digital Forensics Market ... (Computer Forensics, Network Forensics, Mobile Device Forensics, ... and Region - Global Forecast to 2020" ... By Component (Hardware, Software, and Service), Sub-Segment ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... at the time we are conceived set the course for ... of a new study based on an "experiment of nature" ... DNA the genetic blueprint that determines our make-up ... and 50% from our fathers. Apart from the occasional mutation, ...
... that meshes existing data to produce a clearer ... stimuli. Using this new method, Whitehead Institute and ... toxicity to identify genes and pathways that can ... protein in brain cells are a hallmark of ...
... sleep is a risk: foraging for food, mingling with ... snoozing. How, then, has this seemingly life-threatening behavior ... new study by scientists at North Carolina State University ... sleep, although the sleep comes in widely variable amounts ...
Cached Biology News:'Experiment of nature' examines how mother's diet may impact on child's health 2'Experiment of nature' examines how mother's diet may impact on child's health 3Calculating gene and protein connections in a Parkinson's disease model 2Calculating gene and protein connections in a Parkinson's disease model 3Calculating gene and protein connections in a Parkinson's disease model 4NC State study finds genes important to sleep 2
... ,High Quality, Functionally-Validated, Ion Channel Cell Lines ... having a critical role in nerve and ... function in pain, CNS and the heart. ... investigated in therapeutic areas, such as neuropathic ...
... microarrays are derived from frozen embedded tissue ... control procedures to ensure the highest quality. ... in one block, sectioned at a thickness ... slides. Sections are large (3-5 mm in ...
... Ideal for hand-held applications or for use ... with a hand-held eight-port disposable manifold provides ... a multi-channel pipette. The StatMatic II can ... sizes and can completely fill a microplate ...
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... mounted on coated slides. Sections are large ...
Biology Products: